These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 3617601

  • 1. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
    Avdeev VI, Kuz'mina ZV, Murav'eva NI, Bassalyk LS, Kozachenko VP.
    Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
    [Abstract] [Full Text] [Related]

  • 2. [Expression of estrogen and progesterone receptors and oncoprotein HER-2 as a marker for clinical course and outcome in endometrioid adenocarcinoma of the uterine body (immunohistologic study)].
    Samsonova EA, Maksimova NA, Urmancheeva AF, Pozharisskiĭ KM.
    Vopr Onkol; 2004; 50(2):196-201. PubMed ID: 15176223
    [Abstract] [Full Text] [Related]

  • 3. Estrogen and progesterone receptors in uterine sarcomas.
    Sutton GP, Stehman FB, Michael H, Young PC, Ehrlich CE.
    Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
    [Abstract] [Full Text] [Related]

  • 4. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice.
    Friedl A, Gottardis MM, Pink J, Buchler DA, Jordan VC.
    Cancer Res; 1989 Sep 01; 49(17):4758-64. PubMed ID: 2758409
    [Abstract] [Full Text] [Related]

  • 5. The prognostic importance of steroid receptors in endometrial carcinoma.
    Palmer DC, Muir IM, Alexander AI, Cauchi M, Bennett RC, Quinn MA.
    Obstet Gynecol; 1988 Sep 01; 72(3 Pt 1):388-93. PubMed ID: 3405554
    [Abstract] [Full Text] [Related]

  • 6. [Steroid hormone receptors and survival in breast cancer patients].
    Ivanova OA, Tsyrlina EV, Moiseenko VM, Semiglazov VF.
    Vopr Onkol; 1986 Sep 01; 32(6):71-6. PubMed ID: 3727485
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Correlation between estrogen receptor(ER), progesterone receptor(PR) and human keratin protein (hKP) in endometrial carcinoma].
    Hatae M, Yagi Y.
    Gan No Rinsho; 1983 Dec 01; 29(15):1740-9. PubMed ID: 6199529
    [Abstract] [Full Text] [Related]

  • 9. [Measurement of estrogen receptor and progesterone receptor in human endometrium and endometrial carcinoma].
    Itoh E.
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr 20; 25(4):812-20. PubMed ID: 2196312
    [Abstract] [Full Text] [Related]

  • 10. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
    Ehrlich CE, Young PC, Stehman FB, Sutton GP, Alford WM.
    Am J Obstet Gynecol; 1988 Apr 20; 158(4):796-807. PubMed ID: 2966586
    [Abstract] [Full Text] [Related]

  • 11. [Estrogen and progesterone receptors in endometrial carcinoma].
    Guo Y, Dang Q.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jul 20; 32(7):418-21. PubMed ID: 9639729
    [Abstract] [Full Text] [Related]

  • 12. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
    Ciocca DR, Puy LA, Fasoli LC.
    Cancer Res; 1989 Aug 01; 49(15):4298-304. PubMed ID: 2743317
    [Abstract] [Full Text] [Related]

  • 13. Quality control study of estradiol and progesterone receptor determination.
    Vermousek I, Számel I.
    Neoplasma; 1988 Aug 01; 35(3):307-14. PubMed ID: 3405339
    [Abstract] [Full Text] [Related]

  • 14. The distribution and prognostic implications of steroid receptors in endometrial carcinomas.
    Utaaker E, Iversen OE, Skaarland E.
    Gynecol Oncol; 1987 Sep 01; 28(1):89-100. PubMed ID: 3653774
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
    Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW.
    Mod Pathol; 2000 Apr 01; 13(4):379-88. PubMed ID: 10786803
    [Abstract] [Full Text] [Related]

  • 16. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
    Ehrlich CE, Young PC, Cleary RE.
    Am J Obstet Gynecol; 1981 Nov 01; 141(5):539-46. PubMed ID: 6457531
    [Abstract] [Full Text] [Related]

  • 17. [Histopathological changes in endometrial cancer treated with tamoxifen].
    Lin HH, Ueda K, Kato J.
    Gan To Kagaku Ryoho; 1986 Apr 01; 13(4 Pt 1):1038-43. PubMed ID: 3963849
    [Abstract] [Full Text] [Related]

  • 18. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.
    van de Ven J, Sprong M, Donker GH, Thijssen JH, Mak-Kregar S, Blankenstein MA.
    Gynecol Endocrinol; 2001 Dec 01; 15 Suppl 6():61-8. PubMed ID: 12227888
    [Abstract] [Full Text] [Related]

  • 19. Relapse of endometrial carcinoma related to steroid receptor concentration, staging, histologic grading and myometrial invasion.
    Lindahl B, Alm P, Fernö M, Grundsell H, Norgren A, Tropé C.
    Anticancer Res; 1986 Dec 01; 6(6):1317-20. PubMed ID: 3813487
    [Abstract] [Full Text] [Related]

  • 20. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
    Macías A, Pascual MR, Pérez R, Lage A.
    Neoplasma; 1983 Dec 01; 30(5):593-601. PubMed ID: 6656963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.